T'Sjoen G - Search Results

1

Gender-affirming treatment and mental health diagnoses in Danish transgender persons: a nationwide register-based cohort study.

Glintborg D, Møller JK, Rubin KH, Lidegaard Ø, T'Sjoen G, Larsen MJØ, Hilden M, Andersen MS. Glintborg D, et al. Eur J Endocrinol. 2023 Sep 1;189(3):336-345. doi: 10.1093/ejendo/lvad119. Eur J Endocrinol. 2023. PMID: 37672620

2

Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels.

Elaut E, De Cuypere G, De Sutter P, Gijs L, Van Trotsenburg M, Heylens G, Kaufman JM, Rubens R, T'Sjoen G. Elaut E, et al. Eur J Endocrinol. 2008 Mar;158(3):393-9. doi: 10.1530/EJE-07-0511. Eur J Endocrinol. 2008. PMID: 18299474

3

Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration.

Wierckx K, Elaut E, Van Caenegem E, Van De Peer F, Dedecker D, Van Houdenhove E, T'Sjoen G. Wierckx K, et al. Eur J Endocrinol. 2011 Aug;165(2):331-7. doi: 10.1530/EJE-11-0250. Epub 2011 May 20. Eur J Endocrinol. 2011. PMID: 21602316

4

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.

Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, Kaufman JM, T'Sjoen G. Wierckx K, et al. Eur J Endocrinol. 2013 Sep 13;169(4):471-8. doi: 10.1530/EJE-13-0493. Print 2013 Oct. Eur J Endocrinol. 2013. PMID: 23904280

5

Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study.

Klaver M, de Blok CJM, Wiepjes CM, Nota NM, Dekker MJHJ, de Mutsert R, Schreiner T, Fisher AD, T'Sjoen G, den Heijer M. Klaver M, et al. Eur J Endocrinol. 2018 Feb;178(2):163-171. doi: 10.1530/EJE-17-0496. Epub 2017 Nov 28. Eur J Endocrinol. 2018. PMID: 29183889

6

Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.

van Velzen DM, Nota NM, Simsek S, Conemans EB, T'Sjoen G, den Heijer M. van Velzen DM, et al. Eur J Endocrinol. 2020 Nov;183(5):529-536. doi: 10.1530/EJE-20-0609. Eur J Endocrinol. 2020. PMID: 33071222

7

Effects of testosterone therapy on constructs related to aggression in transgender men: A systematic review.

Kristensen TT, Christensen LL, Frystyk J, Glintborg D, T'Sjoen G, Roessler KK, Andersen MS. Kristensen TT, et al. Horm Behav. 2021 Feb;128:104912. doi: 10.1016/j.yhbeh.2020.104912. Epub 2020 Dec 24. Horm Behav. 2021. PMID: 33309817 Review.

8

Masculinising testosterone treatment and effects on preclinical cardiovascular disease, muscle strength and power, aggression, physical fitness and respiratory function in transgender men: protocol for a 10-year, prospective, observational cohort study in Denmark at the Body Identity Clinic (BIC).

Lehmann Christensen L, Glintborg D, Taulbjerg Kristensen T, Diederichsen A, T'Sjoen G, Frystyk J, Skovsager Andersen M. Lehmann Christensen L, et al. BMJ Open. 2020 Dec 29;10(12):e045714. doi: 10.1136/bmjopen-2020-045714. BMJ Open. 2020. PMID: 33376186 Free PMC article.

9

Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?

Stangl TA, Wiepjes CM, Defreyne J, Conemans E, D Fisher A, Schreiner T, T'Sjoen G, den Heijer M. Stangl TA, et al. Eur J Endocrinol. 2021 Apr;184(4):513-520. doi: 10.1530/EJE-20-1064. Eur J Endocrinol. 2021. PMID: 33524005

10

MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.

Glintborg D, T'Sjoen G, Ravn P, Andersen MS. Glintborg D, et al. Eur J Endocrinol. 2021 Jun 28;185(2):R49-R63. doi: 10.1530/EJE-21-0059. Eur J Endocrinol. 2021. PMID: 34081614 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page